Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy

Fig. 1

Influence of KLRG1 expression on LUAD survival and immunotherapy responses. A Expression of KLRG1 in 22 nonsquamous lung carcinoma patients with different response after PD-1 blockade. P values are derived from two-tailed unpaired Student’s t-test. B Kaplan–Meier curves of progression-free survival in the 22 nonsquamous lung carcinoma patients based on the mRNA expression of KLRG1. C Receiver operating characteristic curves for estimating the prognostic value of KLRG1 after PD-1 blockade. D Expression of KLRG1 in LUAD and normal lung tissues. The method for differential analysis is one-way ANOVA, using disease state (Tumor or Normal) as variable for calculating differential expression. E Kaplan–Meier curves of OS in LUAD based on the mRNA expression of KLRG1. F Kaplan–Meier curves of RFS in LUAD based on the mRNA expression of KLRG1. Data represent mean ± SD. **, P < 0.01, ***, P < 0.001

Back to article page